Bristol Myers Squibb Stock Price on May 22, 3024
BMY Stock | USD 58.78 0.09 0.15% |
Below is the normalized historical share price chart for Bristol Myers Squibb extending back to June 01, 1972. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bristol Myers stands at 58.78, as last reported on the 25th of November, with the highest price reaching 60.68 and the lowest price hitting 58.63 during the day.
If you're considering investing in Bristol Stock, it is important to understand the factors that can impact its price. Bristol Myers appears to be very steady, given 3 months investment horizon. Bristol Myers Squibb secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bristol Myers Squibb, which you can use to evaluate the volatility of the firm. Please makes use of Bristol Myers' Downside Deviation of 1.49, risk adjusted performance of 0.1454, and Mean Deviation of 1.31 to double-check if our risk estimates are consistent with your expectations.
At this time, Bristol Myers' Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 2 B in 2024, whereas Total Stockholder Equity is likely to drop slightly above 15 B in 2024. . At this time, Bristol Myers' Price To Sales Ratio is fairly stable compared to the past year. Price Earnings Ratio is likely to rise to 19.89 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop 7.28 in 2024. Bristol Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of January 1972 | 200 Day MA 48.5355 | 50 Day MA 53.6568 | Beta 0.441 |
Bristol |
Sharpe Ratio = 0.1751
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | BMY | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.0 actual daily | 17 83% of assets are more volatile |
Expected Return
0.35 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
0.18 actual daily | 13 87% of assets perform better |
Based on monthly moving average Bristol Myers is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bristol Myers by adding it to a well-diversified portfolio.
Price Book 6.9653 | Enterprise Value Ebitda 32.0853 | Price Sales 2.5171 | Shares Float 2 B | Dividend Share 2.4 |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About Bristol Myers Stock history
Bristol Myers investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bristol is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bristol Myers Squibb will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bristol Myers stock prices may prove useful in developing a viable investing in Bristol Myers
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 2.1 B | 1.6 B | |
Net Income Applicable To Common Shares | 5.7 B | 6 B |
Bristol Myers Quarterly Net Working Capital |
|
Bristol Myers Stock Technical Analysis
Bristol Myers technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bristol Myers Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Bristol Myers Squibb cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bristol Myers November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Bristol Myers stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bristol Myers shares will generate the highest return on investment. By undertsting and applying Bristol Myers stock market strength indicators, traders can identify Bristol Myers Squibb entry and exit signals to maximize returns
Bristol Myers Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bristol Myers' price direction in advance. Along with the technical and fundamental analysis of Bristol Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bristol to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1454 | |||
Jensen Alpha | 0.3339 | |||
Total Risk Alpha | 0.0375 | |||
Sortino Ratio | 0.1523 | |||
Treynor Ratio | 3.11 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.